Deep Venous Thrombosis with Pulmonary Embolism Related to IVIg Treatment: A Case Report and Literature Review

Abstract EN

IVIg therapy has potentially been related to arterial and venous therapy.

We performed an Ovid review focusing on IVIg and thrombotic events.

While a few case reports were reviewed case series and case control studies were particularly reviewed in relation to thrombotic events.

Outcomes demonstrate a correlation between underlying cardiovascular risk factors with predominately arterial events which typically occurred within 4–24 hours of infusion.

While venous events occurred less commonly they were associated with traditional risk factors and occurred later, typically, 1–7 days following infusion of IVIg.

Potential causation of thrombotic events was discussed.